Attitudes of French populations towards the disclosure of unsolicited findings in medical genetics.

biomedical ethics disclosure to patients medical genetics next-generation sequencing unsolicited findings

Journal

Journal of health psychology
ISSN: 1461-7277
Titre abrégé: J Health Psychol
Pays: England
ID NLM: 9703616

Informations de publication

Date de publication:
09 2021
Historique:
pubmed: 12 11 2019
medline: 9 9 2021
entrez: 12 11 2019
Statut: ppublish

Résumé

Next-generation sequencing techniques enable unsolicited findings to be detected. This discovery raises ethical questions concerning the return of these findings. Our study aimed to highlight the views of the general public, patients under supervision and health professionals concerning the acceptability of disclosing unsolicited results to patients. In total, 449 participants assessed scenarios, consisted of all combinations of three factors (patient's information and consent, prevention and treatment of the unsolicited disease and doctor's decision). The response profiles were grouped into six clusters. The participants took ethical aspects into account, but health professionals also considered the medical aspects to a greater extent.

Identifiants

pubmed: 31707852
doi: 10.1177/1359105319886622
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1767-1779

Auteurs

Marion Rosier (M)

Université de Toulouse, France.

Myriam Guedj (M)

Université de Toulouse, France.

Patrick Calvas (P)

Hôpital Purpan, France.

Sophie Julia (S)

Inserm UMR 1027, France.

Christelle Garnier (C)

Hôpital Purpan, France.

Anne Cambon-Thomsen (A)

Inserm UMR 1027, France.

Maria Teresa Muñoz Sastre (MT)

Université de Toulouse, France.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH